126 related articles for article (PubMed ID: 17964984)
21. [Renal infiltrate by a plasmocytoïd chronic B lymphocytic leukaemia and renal failure: a rare occurrence in nephropathology. A case report and review of the literature].
Aymard B; Beghoura R; Molina TJ
Nephrol Ther; 2011 Nov; 7(6):479-87. PubMed ID: 21439927
[TBL] [Abstract][Full Text] [Related]
22. Richter's transformation of chronic lymphocytic leukemia.
Giardino AA; O'Regan K; Jagannathan JP; Elco C; Ramaiya N; Lacasce A
J Clin Oncol; 2011 Apr; 29(10):e274-6. PubMed ID: 21220587
[No Abstract] [Full Text] [Related]
23. Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features.
Rodriguez J; McLaughlin P; Hagemeister FB; Fayad L; Rodriguez MA; Santiago M; Hess M; Romaguera J; Cabanillas F
Blood; 1999 Apr; 93(7):2202-7. PubMed ID: 10090928
[TBL] [Abstract][Full Text] [Related]
24. Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group.
Hiddemann W; Unterhalt M; Herrmann R; Wöltjen HH; Kreuser ED; Trümper L; Reuss-Borst M; Terhardt-Kasten E; Busch M; Neubauer A; Kaiser U; Hanrath RD; Middeke H; Helm G; Freund M; Stein H; Tiemann M; Parwaresch R
J Clin Oncol; 1998 May; 16(5):1922-30. PubMed ID: 9586911
[TBL] [Abstract][Full Text] [Related]
25. [High-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma].
Provencio M; Fayad LE
Med Clin (Barc); 2008 Jan; 130(2):60-5. PubMed ID: 18221676
[No Abstract] [Full Text] [Related]
26. Primary gastrointestinal follicular lymphoma: single-center 12-year experiences.
Na YJ; Kim ER; Kim SJ; Kim WS; Ko YH; Son HJ
Hepatogastroenterology; 2012 May; 59(115):751-3. PubMed ID: 22020908
[TBL] [Abstract][Full Text] [Related]
27. Salvage central lymphatic irradiation in follicular lymphomas following failure of chemotherapy: a feasibility study.
Ha CS; Tucker SL; Blanco AI; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1207-12. PubMed ID: 10613314
[TBL] [Abstract][Full Text] [Related]
28. [Progress in hematological malignancy of aged--therapy of malignant lymphoma in aged].
Mori M
Nihon Ronen Igakkai Zasshi; 1992 Mar; 29(3):157-60. PubMed ID: 1375668
[No Abstract] [Full Text] [Related]
29. Clinicopathologic features of early lesions of primary cutaneous follicle center lymphoma, diffuse type: implications for early diagnosis and treatment.
Gulia A; Saggini A; Wiesner T; Fink-Puches R; Argenyi Z; Ferrara G; Müller CS; Vale E; Cerroni L
J Am Acad Dermatol; 2011 Nov; 65(5):991-1000. PubMed ID: 21704419
[TBL] [Abstract][Full Text] [Related]
30. Primary peripheral nodal lymphoma in children.
Wollner N; Exelby P; Lindsley KL; Lieberman P; Filippa D; Heller G
Cancer; 1993 Jun; 71(11):3670-9. PubMed ID: 8490916
[TBL] [Abstract][Full Text] [Related]
31. Prolonged disease-free survival and overall survival with CVP alternating with fludarabine in advanced follicular lymphoma.
Ai WZ; Kohrt HE; Timmerman J; Hwang J; Hsu FJ; Czerwinski DD; Taidi B; Levy R
Am J Hematol; 2011 Jun; 86(6):515-8. PubMed ID: 21538469
[No Abstract] [Full Text] [Related]
32. Childhood malignant non-Hodgkin lymphomas of uncommon histology.
Ribeiro RC; Pui CH; Murphy SB; Shuster JJ; Hvizdala EV; Falletta J; Link MP; Sullivan MP; Pick TE; Sandlund JT
Leukemia; 1992 Aug; 6(8):761-5. PubMed ID: 1640726
[TBL] [Abstract][Full Text] [Related]
33. Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model.
Romaguera JE; McLaughlin P; North L; Dixon D; Silvermintz KB; Garnsey LA; Velasquez WS; Hagemeister FB; Cabanillas F
J Clin Oncol; 1991 May; 9(5):762-9. PubMed ID: 1707956
[TBL] [Abstract][Full Text] [Related]
34. Management of the indolent non-Hodgkin's lymphomas.
Portlock CS
Semin Oncol; 1980 Sep; 7(3):292-301. PubMed ID: 6158100
[No Abstract] [Full Text] [Related]
35. The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological origin.
Czuczman MS; Vose JM; Witzig TE; Zinzani PL; Buckstein R; Polikoff J; Li J; Pietronigro D; Ervin-Haynes A; Reeder CB
Br J Haematol; 2011 Aug; 154(4):477-81. PubMed ID: 21707581
[TBL] [Abstract][Full Text] [Related]
36. Interferon alpha 2b as maintenance therapy improves outcome in follicular lymphoma.
Avilés A; Neri N; Huerta-Guzmán J; Pérez F; Sotelo L
Leuk Lymphoma; 2004 Nov; 45(11):2247-51. PubMed ID: 15512813
[TBL] [Abstract][Full Text] [Related]
37. Incidence, risk factors and outcome of histological transformation in follicular lymphoma.
Conconi A; Ponzio C; Lobetti-Bodoni C; Motta M; Rancoita PM; Stathis A; Moccia AA; Mazzucchelli L; Bertoni F; Ghielmini M; Cavalli F; Zucca E
Br J Haematol; 2012 Apr; 157(2):188-96. PubMed ID: 22348437
[TBL] [Abstract][Full Text] [Related]
38. Long-term survival after histologic transformation of low-grade follicular lymphoma.
Yuen AR; Kamel OW; Halpern J; Horning SJ
J Clin Oncol; 1995 Jul; 13(7):1726-33. PubMed ID: 7602362
[TBL] [Abstract][Full Text] [Related]
39. [Malignant lymphoma: individualized treatment according to biological and clinical risk factors].
Dreyling M
Dtsch Med Wochenschr; 2011 Apr; 136(14):687-90. PubMed ID: 21448827
[No Abstract] [Full Text] [Related]
40. [Secondary orbital lymphoma].
Basanta I; Sevillano C; Álvarez MD
Arch Soc Esp Oftalmol; 2015 Sep; 90(9):442-4. PubMed ID: 25443214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
